How big is the Renal Biomarkers Market?

The Renal Biomarkers Market size is expected to reach USD 1.5 billion in 2024 and grow at a CAGR of 7.53% to reach USD 2.20 billion by 2029. Read More

What is the current Renal Biomarkers Market size?

In 2024, the Renal Biomarkers Market size is expected to reach USD 1.5 billion. Read More

Who are the key players in Renal Biomarkers Market?

Thermo Fischer Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, bioMérieux SA and Siemens Healthineers are the major companies operating in the Renal Biomarkers Market. Read More

Which is the fastest growing region in Renal Biomarkers Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Renal Biomarkers Market?

In 2024, the North America accounts for the largest market share in Renal Biomarkers Market. Read More

What years does this Renal Biomarkers Market cover, and what was the market size in 2023?

In 2023, the Renal Biomarkers Market size was estimated at USD 1.39 billion. The report covers the Renal Biomarkers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Renal Biomarkers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Renal Biomarkers Market Share

Statistics for the 2023 & 2024 Renal Biomarkers market share, created by Mordor Intelligence™ Industry Reports. Renal Biomarkers share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Renal Biomarkers Industry

The renal biomarkers market is highly competitive and consists of several major players, along with multiple smaller companies. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies at affordable prices. Companies like Thermofisher Scientific, Abbott Laboratories, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, and BioMérieux hold substantial shares in the market.